ArticleApplied biosafety : journal of the American Biological Safety Association2025
Optimizing Biological Indicator Placement for Validating High-Efficiency Particulate Air Housing Decontamination.
Article in Applied biosafety : journal of the American Biological Safety Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The validation of high-efficiency particulate air (HEPA) housing decontamination efficacy is crucial for maintaining critical environments and is normally assessed by positioning biological indicators at the downstream port (filtered side) before the decontamination cycle. This method is favored for its significantly lower biohazard risk. HEPA housings and filters typically designed for high airflow face challenges during decontamination due to the diameters and positions of upstream and downstream ports, potentially impacting the distribution of decontamination agents. Objective: This study investigates the effectiveness of this prevalent validation method, particularly focusing on the uniformity of decontamination agent dispersion across the HEPA filter. Methods: Preparation: HEPA filters and housings were set up in a controlled environment. Placement of Biological Indicators: Indicators were positioned at multiple points, including the downstream port and various peripheral regions of the filter. Decontamination Cycle: The decontamination process was initiated using a standard protocol for hydrogen peroxide vapor or another selected agent. Measurement: The concentration of decontamination agents was measured at each indicator position using appropriate detection techniques. Analysis: Data were analyzed to assess the uniformity of decontamination agent distribution and identify any significant variations across different areas of the filter. Results: Our findings reveal a notable variability in the concentration of decontamination agents across different areas of the HEPA filter, especially in peripheral regions. Such variability poses questions about the current method's ability to ensure comprehensive decontamination, given that the concentration at the exit port does not accurately reflect exposure across all filter surfaces. This discrepancy between expected and actual decontamination efficacy underscores the need for optimization in decontamination practices. Conclusion: The discrepancy between expected and actual decontamination efficacy underscores the need for optimization in decontamination practices. This study highlights the importance of validating decontamination methods and sets the stage for future research aimed at enhancing the uniformity of agent exposure across the HEPA filter. This study advocates for further investigation into methods that could ensure more reliable and effective decontamination, which is vital for biorisk management and the prevention of pathogen contamination.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.